International
International
2009 1. Invited talk. Advanced breast cancer, uterine sarcoma, irresectable neck
nodes and maxillary sinus tumours treated with neutron therapy.
C. Stannard, E. Murray, L. v Wijk, M. Maurel, P. Kraus, F. Vernimmen,
S. Fredericks, S. De Canha. 1st Romanian Society of Hadrontherapy
Workshop, Predeal, Romania. February/March 2009
2007 2. Poster: Vandetanib with Docetaxel as second-line treatment for
advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study. K. Boér, I. Láng, A. Llombart-Cussac,
I. Andreasson, G.L. Vivanco, N. Sanders, G.M. Pover and E. Murray.
San Antonio Breast Cancer Symposium, December 2007.
2007 3. Invited Speaker: African Organisation for Research & Training in
Cancer (AORTIC), October 2007, Cape Town. Plenary Session: Management of Breast Cancer in Africa
2007 4. Poster: A study to investigate the role of p27 and cyclin E
immunoexpression as a prognostic factor in early breast carcinoma.
K. Pillay, R. Chetty, H. McCleod, E.M. Murray, P. Hall. Primary Therapy of Early Breast Cancer 10th International Conference, St. Gallen, Switzerland March 2007
2006 5. Poster: Neutron vs photon radiotherapy in locally advanced breast
cancer with or without metastases. E.M. Murray, I.D. Werner, G. Schmitt, C. Stannard, A. Gudgeon, J. Wilson, J. Harris, S. Fredericks, E. McEvoy,
E. Nel, S. De Canha* International Workshop On Fast Neutron Therapy, Essen, 14-16 September 2006 *presenting author
2006 6. Importance of number of examined axillary lymph nodes for assessing
the risk of locoregional recurrence (LRR) among breast cancer patients with 1-3 lymph node metastases. P. Karlsson, B.F. Cole, M. Castiglione-Gertsch, B.A. Gusterson, J. Lindtner, J.P. Collins, M. Fey, E. Murray,
A. Goldhirsch, A. Wallgren for the International Breast Cancer Study Group.
European Breast Cancer Conference, Nice, France 21-25 March 2006.
2003 7. Invited Speaker: Breast Cancer in Developing Countries. (AORTIC) IV
International Conference on Cancer in Africa: Meeting the Challenges of the 21st Century, Accra, Ghana, 6-10 October 2003.
2003 8. Quality-adjusted survival (QAS) in patients with postmenopausal breast
cancer using patient-rated utilities to extend the Q-TwiST concept.
J. Bernhard, D. Zahrieh, A. Coates, R. Gelber, M. Castiglione-Gertsch,
E. Murray, J. Forbes, L. Perey, A. Goldhirsch, C. Hürny, for the International Breast Cancer Study Group (IBCSG). American Society of Clinical Oncology Annual Meeting, Chicago, Illinois, United States of America, 31 May - 3 June 2003.
2002 9. Biological markers (BM) with predictive value in metastatic breast
cancer (MBC) patients (PTS) randomly treated with doxorubicin (A) or docetaxel (D). A. Di Leo, S. Chan, K Friederichs, T. Pinter, S. Van Belle,
E. Murray, I. Bodrogi, E. Walpole, B. Lesperance, S. Korec, J. Crown,
P. Simmonds, S. Dolci, D. Larsimont, N. Azli, C. Dumontet, J. Isola,
M. Paesmans, M.J. Piccart on behalf of the TAX 303 Translational Research Study. American Society of Clinical Oncology (ASCO) Annual Meeting, Orlando, Florida, 18-21 May 2002.
2001 10. Invited speaker: Symposium - Breast cancer in developing countries: Locally advanced breast cancer. Topic: Medical & Radiation Oncology in a
developing country. E. Murray International Surgical Week ISW2001, Brussels, Belgium 26-30 August 2001.
1999 11. Treatment with chemotherapy alone is inadequate for very young women with estrogen receptor positive breast cancer. Results from the
International Breast Cancer Study Group (IBCSG) Trials I, II, V and VI.
S. Aevi, S. Gelber, M. Castiglione-Gertsch, R.D. Gelber, J. Collins,
B. Thurlimann, C.M.Rudenstam, J. Lindtner, A. Veronesi, H. Cortes-Funes, E. Simoncini, E. Murray, A.S. Coates, A. Goldhirsch, for the IBCSG, Bern, Switzerland American Society Of Clinical Oncology (ASCO) Annual Meeting, May 1999.
1997 12. Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in
previously untreated advanced breast cancer (ABC). D. Vorobiof,
L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,
E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,
I. Lepape, J.P. Burillon, S. Le Couturier. 9th European Conference on Clinical Oncology (ECCO9), Hamburg, Germany, 14-18 September, 1997.
1997 13. Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in
previously untreated advanced breast cancer (ABC). D. Vorobiof,
L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,
E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,
I. Lepape, J.P. Burillon, S. Le Couturier. American Society of Clinical Oncology (ASCO) Annual Meeting 1997, Denver, Colorado, United States of America, 17-20 May 1997.
1994 14. Breast conservation for early breast cancer. V. Pervan, A. Gudgeon,
I.D. Werner, E. Murray. 8th International Conference on Cancer Nursing, Vancouver, Canada, 7-12 August 1994
1994 15. Neutron irradiation in advanced breast cancer. E. Kwatsha, E. Murray,
A. Gudgeon, I.D. Werner 8th International Conference on Cancer Nursing, Vancouver, Canada, 7-12 August 1994
5.2 Local
2012 1. Invited Speaker The time has come for partial breast irradiation?
E. Murray. Surgical Update Conference. University of Cape Town. March2012
2012 2. Invited Speaker Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Family Medicine Registrars Seminar March 2012
2012 3. Session Chair ICON conference Breast Cancer Session March 2012
2009 4. Beyond CAF: Chemotherapy and biological agents in breast cancer.
E. Murray. Surgical Update Congress, University of Cape Town.
March 2009
2009 5. Radiotherapy and Reconstruction in Breast Cancer. E. Murray
National Plastic Surgeons Registrar Congress. University of Cape Town
March 2009
2009 6. Distinct clinical and prognostic features of infiltrating lobular carcinoma
of the breast: Combined results of 15 International Breast Cancer Study group clinical trials. B.C. Pestalozzi, D. Zahrieh, E. Mall, B.A. Gusterson, K.N. Price, R.D. Gelber, S.B. Holmberg, J. Lindtner, R. Snyder, B. Thürlimann, E. Murray, G. Viale, M. Castiglione- Gertsch, A.S. Caotes and A. Goldhirsch. South African Society Medical Oncology/South African Society Clinical Radiation Oncology (SASMO/SASCRO) Congress. Cape Town CTICC, February 2009
2009 7. Multi-Disciplinary Clinics in Oncology/Breast Cancer E.Murray Surgical
Oncology Congress, Johannesburg. February 2009
2007 8. A post-mastectomy radiotherapy technique for centres with limited
resources. J. Hough, E. Murray, K. Botha. South African Society Medical Oncology/South African Society Clinical Radiation Oncology (SASMO/SASCRO) Congress,
Drakensberg, April 2007
2006 9. Invited speaker: The treatment of breast cancer in Africa
IAEA Nobel Peace Prize Event, UCT Breakwater Lodge, Cape Town
December 2006.
2005 10. Site of the primary tumour has a prognostic role in operable breast
cancer: The IBCSG experience. Presented by E. Murray for the IBCSG
M. Colleoni, D. Zahrieh, R.D. Gelber, S.B. Holmberg, J.E. Mattson,
C-M Rudenstam, J. Lindtner, D. Eržen, R. Snyder, J. Collins, M.F. Fey,
B. Thürlimann, D. Crivellari, E. Murray, C. Mendiola, O. Pagani,
M. Castiglione-Gertsch, A.S.Coates, K. Price, A. Goldhirsch for the International Breast Cancer Study Group. SASMO/SASCRO, Wild Coast Sun, South Africa, 2005
2004 11. Invited speaker: The management of locally advanced breast cancer.
24th Biennial Congress of The Association of Surgeons of SA, Cape Town Convention Centre, August 2004
2004 12. Primary male breast cancer (Poster presentation) M. Selepe, C. Honnibal,
D. Dent, D. Werner, E. Murray, P. Hall PATH Splash 2004 Congress, Stellenbosch, 2004.
2003 13. Poster: Neutron versus Photon Radiotherapy in Locally Advanced
Breast Cancer (LABC) With or Without Metastases. E.M. Murray, I.D. Werner, G. Schmitt, C. Stannard, A. Gudgeon, J. Wilson, J. Harris, S. Fredericks, E. McEvoy, E. Nel 11th SASMO/SASCRO Congress, Bloemfontein March 2003.
2003 14. CMF vs CMF and Tamoxifen in Post Menopausal Lymph Node Negative
Breast Cancer. Presented by E. Murray for the IBCSG
11th SASMO/SASCRO Congress, Bloemfontein March 2003.
2002 15. Invited speaker: Breast cancer: Medical and Radiation Oncology in
Developing Countries with particular emphasis on locally advanced breast cancer. Pre-Congress Workshop: Congress of The South African Society of Nuclear Medicine, 3 December, Stellenbosch, 2002
2001 16. Medical and Radiation Oncology for Breast Cancer in Developing
Countries/Locally Advanced Breast Cancer. E. Murray SASMO/SASCRO Congress, Muldersdrift, September 2001.
2001 17. Invited speaker: Postmastectomy radiotherapy.
Plastic Surgery National Registrars’ Symposium, University of Cape Town. July 2001.
2001 18. Skin sparing mastectomy and immediate reconstruction for breast
cancer: oncological considerations. W. Ddamulira, E. Panieri, D.A. Hudson, D.M. Dent, E. Murray, D. Werner. Surgical Research Society (SRS) Conference, Johannesburg. July 2001
2000 19. Neutron therapy at the National Accelerator Centre. C. Stannard,
F. Vernimmen, E. Murray, L. Van Wijk, J. Harris, R Abratt, V. Levin, E. Mills, J. Wilson 1st International Congress Of The South African Radiobiology Society, Stellenbosch. December 2000.
2000 20. Breast reconstruction after mastectomy: Who are candidates?
E. Panieri, D. Lazarus, D. Hudson, E. Murray, D.M. Dent. ASSA Congress Port Elizabeth, South Africa. November 2000
2000 21. Poster – When benign becomes malignant: A breast odyssey.
I.D.Werner, N Simons, D A Taylor, E M Murray, J Apffelstaedt Society of Radiographers Congress, Cape Town, September, 2000.
1998 22. Current trials at the National Accelerator Centre. C. Stannard,
F. Vernimmen, L. Van Wijk, D. Werner, E. Murray, S. Fredericks. SASMO/SASCRO Congress, Cape Town, October 1998.
1997 23. Phase II study of I.V. Navelbine (NVB) and Doxorubicin (DOX) in
previously untreated advanced breast cancer (ABC). D. Vorobiof,
L. Goedhals, P. Barnardt, A. Gudgeon, A. Van Der Merwe, L. Smith,
E. Murray, D. Pretorius, P. Bassompierre, E. Bergonzoli, F.M. Delgado,
I. Lepape, J.P. Burillon, S. Le Couturier. SASMO/SASCRO Congress, Durban, March 1997
1997 24. 8 years of particle therapy at the NationalAccelerator Centre.
C. Stannard, J. Wilson, F. Vernimmen, D. Jones,N. Schreuder, J. Symons,
E. Murray, L. Van Wijk, C. Johnson, R. Abratt. SASMO/SASCRO Congress, Durban, March 1997
1997 25. Trial of photons versus neutrons in locally advanced breast cancer.
I.D. Werner, E.M. Murray, C.A. Gudgeon, C.E. Stannard, A. Visser.
Combined Congress SASMO/SASCRO Durban, March 1997.
1996 26. Invited Speaker: Treatment Options in Breast Cancer. Regional Training
Course on Techniques and Dosimetry in Interstitial Brachytherapy. International Atomic Energy Agency in Collaboration with the Departments of Radiation Oncology and Medical Physics, Groote Schuur Hospital and the University of Cape Town. April 1996.
1995 27. Postradiation sarcomas: A review of 2O cases. E.M. Murray, E. Greeff,
D. Taylor, M. Garb, I.D. Werner. Combined Congress Of The South African Society of Medical Oncologists SASMO/SASCRO Congress, Thaba 'Nchu, September 1995. Awarded Congress poster prize.
1995 28. The National Neutron Therapy Programme. C. Stannard, F. Vernimmen,
L. van Wijk, S. Brennan, A.M. Visser, C. Johnson, J. Wilson, V. Levin,
E. Mills, A. Alberts, D. Werner, B. Smit, G. Schmitt, D. Kranold, E. Murray,
A. Gudgeon, N. Bental, R. Abratt, J. Kiley, A. van der Merwe, R. Keuler,
B. L. Goedhals, H. Krawitz, B. Donde, S. Bairston, D. Friediger, A. Dreyer,
V. Reddi, M. Morgan SASMO/SASCRO Congress, Thaba 'Nchu. September 1995.
1995 29. Breast carcinoma at Groote Schuur Hospital. A 25-year retrospective.
I.D. Werner, A. Gudgeon, E. Murray, E. Timotheus. SASMO/SASCRO Congress, Thaba 'Nchu, September 1995.
1995 30. Invited Speaker: Breast Symposium, Constantiaberg Hospital, Cape Town,
May 1995. Presentation on Treatment of Metastatic Disease.
1994 31. Invited Lecture: New trends in therapy. E. Murray, A. Gudgeon, D.M. Dent.
University of Cape Town Extra-Mural Course 1994, University of Cape Town. May 1994.
1990 32. Irradiation induced malignancy after radiotherapy for breast carcinoma.
E. Murray, E. Greeff, M. Hanly, C. A. Gudgeon, D.M. Dent, E.A. Hacking.
3th National Congress of The South African Society of Radiotherapists, Wild Coast Sun, Transkei. April 1990.
5.3 Presentations at Refresher/Educational courses
2006 Invited speaker: The treatment of breast cancer in Africa
IAEA Nobel Peace Prize Event, UCT Breakwater Lodge, Cape Town
2001 Invited speaker: Postmastectomy radiotherapy.
Plastic Surgery National Registrars’ Symposium
University of Cape Town.
1996. Invited Speaker: Treatment Options in Breast Cancer. Regional Training
Course on Techniques and Dosimetry in Interstitial Brachytherapy. International Atomic Energy Agency in Collaboration with the Departments of Radiation Oncology and Medical Physics, Groote Schuur Hospital and the University of Cape Town.
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- overview patientpop
- proposal for implementing primary health care and health
- international
- the business of influence principles that lead to success
- mental health treatment study
- abd e news iowa
- dirty business american chemical society
- education
- law of non profit organizations fall 2004
- avon calls on foreign markets
Related searches
- international education management inema
- the role of international business
- the role of international customs
- role of international finance
- roles of international law
- best international schools in dubai
- why is international travel important
- why international travel is important
- international education group llc
- journal of international economics
- international delight caramel macchiato
- international waxes smethport pa